Keyphrases
Prostate Cancer Cells
100%
Therapeutic Implications
100%
Neuroendocrine Differentiation
100%
Dovitinib
100%
TKI258
100%
Neuroendocrine Prostate Cancer
75%
Aggressive Tumor
50%
Resistance Development
50%
Clinical Trials
25%
Tumor
25%
Combination Therapy
25%
Receptor Tyrosine Kinase Inhibitor
25%
Cancer Mortality
25%
Mouse Model
25%
Differentiation Process
25%
Hormone-sensitive Prostate Cancer
25%
Prostate Cancer
25%
Androgen Deprivation Therapy
25%
Cancer Causes
25%
Resistance Mechanisms
25%
Platelet-derived Growth Factor Receptor (PDGFR)
25%
Wnt Signaling Pathway
25%
Prostate Cancer Progression
25%
Castration-resistant Prostate Cancer
25%
Vascular Endothelial Growth Factor Receptor (VEGFR)
25%
Therapy-resistant
25%
Metastatic Tumor
25%
Salvage Therapy
25%
PI3K Signaling Pathway
25%
Anti-androgen Therapy
25%
Prostate Cancer Bone Metastasis
25%
Xenografted Tumor
25%
Androgen Receptor-positive
25%
Cancer Variants
25%
NE Differentiation
25%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Dovitinib
100%
Neoplasm
37%
Malignant Neoplasm
25%
Androgen Receptor
25%
Clinical Trial
12%
Combination Therapy
12%
Androgen
12%
Mouse Model
12%
Protein Tyrosine Kinase
12%
Protein Tyrosine Kinase Inhibitor
12%
Castration Resistant Prostate Cancer
12%
Bone Metastasis
12%
Cancer Growth
12%
Metastasis
12%
Antiandrogen
12%